natgillin/translations-raw huggingface dataset:
As a precautionary measure, it is preferable to avoid the use of Thymanax during pregnancy.
Zaradi previdnosti se je uporabi zdravila Thymanax med nosečnostjo bolje izogniti.
Thymanax is used in adults.
Zdravilo Thymanax se uporablja pri odraslih.
If Thymanax is initiated while tapering the dosage of the previous medicine, possible discontinuation symptoms should not be confounded with a lack of early effect of Thymanax.
Če vam bodo zdravilo Thymanax uvedli že v času zmanjševanja odmerka prejšnjega zdravila, možnih odtegnitvenih simptomov ne smete zamenjati z odsotnostjo zgodnjega učinka zdravila Thymanax.
Thymanax can be taken with or without food.
Zdravilo Thymanax lahko jemljete s hrano ali brez nje.
Be vigilant about signs and symptoms that your liver may not be working properly - If you observe any of these signs and symptoms of liver problems: unusual darkening of the urine, light coloured stools, yellow skin/eyes, pain in the upper right belly, unusual fatigue (especially associated with other symptoms listed above), seek urgent advice from a doctor who may advise you to stop taking Thymanax.
Bodite pozorni na znake in simptome, ki kažejo na morebitno nepravilno delovanje vaših jeter - Če opazite katere koli znake in simptome težav z jetri: neobičajno temen urin, svetlo obarvanje blata, rumena koža/oči, bolečina v zgornjem desnem delu trebuha, neobičajna utrujenost (še posebno, če je povezana z drugimi simptomi, navedenimi zgoraj), nujno poiščite pomoč zdravnika, ki vam bo morda svetoval prenehanje zdravljenja z zdravilom Thymanax.
Thymanax is not recommended in the treatment of depression in patients under 18 years of age since safety and efficacy of Thymanax have not been established in this age group.
Zdravilo Thymanax ni priporočljivo za zdravljenje depresije pri bolnikih, ki so mlajši od 18 let, ker varnosti in učinkovitosti zdravila Thymanax pri tej starostni skupini niso proučevali.
Thymanax film-coated tablets may be taken with or without food.
Filmsko obložene tablete zdravila Thymanax lahko bolniki jemljejo s hrano ali brez nje.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicineThymanax.
Če vam je zdravnik povedal, da ne prenašate nekaterih sladkorjev, se pred uporabo tega zdravila posvetujte s svojim zdravnikom.
During your treatment with Thymanax :
Med zdravljenjem z zdravilom Thymanax:
Some patients may get increased levels of liver enzymes in their blood during treatment with Thymanax.
Pri nekaterih bolnikih se lahko vrednosti jetrnih encimov med jemanjem zdravila Thymanax zvišajo.
Thymanax starts to act on symptoms of depression in most depressed people within two weeks of starting treatment.
Pri večini bolnikov zdravilo Thymanax začne zmanjševati simptome depresije v dveh tednih po začetku zdravljenja.
If you have taken more Thymanax than you should, or if for example a child has taken medicine by accident, contact your doctor immediately.
Če ste vzeli večji odmerek zdravila Thymanax, kot bi smeli Če ste vzeli večji odmerek zdravila Thymanax, kot bi smeli, ali če je na primer zdravilo nehote vzel otrok, takoj obvestite svojega zdravnika.
Other medicines and Thymanax
Druga zdravila in zdravilo Thymanax
If you forget to take Thymanax
Če ste pozabili vzeti zdravilo Thymanax
- If you have increased levels of liver enzymes before treatment, your doctor will decide if Thymanax is right for you.
- Če imate pred zdravljenjem zvišane vrednosti jetrnih encimov, bo vaš zdravnik odločil, ali je zdravilo Thymanax primerno za vas.
INFORMATION IN BRAILLE Thymanax 25 mg
PODATKI V BRAILLOVI PISAVI Thymanax 25 mg
Thymanax should not be used for the treatment of major depressive episodes in elderly patients with dementia since the safety and efficacy of Thymanax have not been established in these patients.
Uporaba pri starejših z demenco Zdravila Thymanax ne smete predpisovati za zdravljenje velikih depresivnih epizod pri starejših bolnikih z demenco, ker varnosti in učinkovitosti zdravila Thymanax pri tovrstnih bolnikih niso proučevali.
• lactose monohydrate, maize starch, povidone (K30), sodium starch glycolate type A, stearic acid, magnesium stearate, colloidal anhydrous silica,hypromellose, glycerol, macrogol (6000), yellow iron oxide (E172) and titanium dioxide (E171).
- Pomožne snovi so: laktoza monohidrat, koruzni škrob, povidon (K30), natrijev karboksimetilškrob (vrsta A), stearinska kislina, magnezijev stearat, brezvoden koloidni silicijev dioksid, hipromeloza, glicerol, makrogol (6000), rumeni železov oksid (E172) in titanov dioksid (E171);
Following discontinuation of Thymanax therapy liver function tests should be repeated until serum transaminases return to normal.
Po prekinitvi zdravljenja z zdravilom Thymanax morate delovanje jeter pregledovati dokler se aminotransferaze v serumu ne vrnejo na normalne vrednosti.
These symptoms may also be due to the underlying disease (see section 4.4).
Ta simptoma sta lahko prisotna tudi kot posledica osnovne bolezni (glejte poglavje stanje zmedenosti*
Thymanax should be used with caution in patients with a history of bipolar disorder, mania or hypomania and should be discontinued if a patient develops manic symptoms (see section 4.8).
Pri bolnikih z bipolarno motnjo, manijo ali hipomanijo v anamnezi morate zdravilo Thymanax uporabljati previdno in zdravljenje prekiniti, če se pri bolniku razvijejo simptomi manije (glejte poglavje 4.8).
Your doctor may continue to give you Thymanax when you are feeling better to prevent your depression from returning.
Zdravnik vam bo morda predpisoval zdravilo Valdoxan tudi še potem, ko se boste že počutili bolje, da bi preprečil ponovitev depresije.
Effect of Thymanax is not documented in patients aged 75 years and older.
Učinka zdravila Thymanax pri bolnikih starih 75 let in več niso dokazali.
Thymanax is indicated for the treatment of major depressive episodes in adults.
4.1 Terapevtske indikacije Zdravilo Thymanax je indicirano za zdravljenje velikih depresivnih epizod pri odraslih.
If your doctor changes your previous antidepressant medicine from an SSRI or SNRI to Thymanax, he/she will advise you on how you should discontinue your previous medicine when starting Thymanax.
Če vam bo zdravnik zamenjal vaš prejšnji antidepresiv iz skupine SSRI ali SNRI z zdravilom Thymanax, vam bo ob uvedbi zdravila Thymanax svetoval o ustreznem načinu prenehanja zdravljenja s prejšnjim zdravilom.
Thymanax with alcohol
Zdravilo Thymanax skupaj z alkoholom
Do not take Thymanax - if you are allergic to agomelatine or any of the other ingredients of this medicine (listed in section
Kaj morate vedeti, preden boste vzeli zdravilo Thymanax Ne jemljite zdravila Thymanax - če ste alergični na agomelatin ali katero koli sestavino tega zdravila (navedeno v poglavju 6),
No evidence of pharmacokinetic or pharmacodynamic interaction with medicinal products which could be prescribed concomitantly with Thymanax in the target population was found in phase I clinical trials: benzodiazepines, lithium, paroxetine, fluconazole and theophylline.
V kliničnih preskušanjih faze I niso opazili dokazov o farmakokinetičnem ali famakodinamičnem medsebojnem delovanju zdravila Thymanax z zdravili, ki jih sočasno predpisujemo pri ciljni skupini bolnikov: benzodiazepini, litijem, paroksetinom, flukonazolom in teofilinom.
Available pharmacodynamic/toxicological data in animals have shown excretion of agomelatine/metabolites in milk (see section 5.3).
toksikološki podatki pri živalih kažejo na izločanje agomelatina/presnovkov v mleko ( glejte poglavje 5.3).
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER Servier (Ireland) Industries Ltd,
IME IN NASLOV IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM Servier (Ireland) Industries Ltd,
You should not take Thymanax together with certain medicines (see also under “Do not take Thymanax” in section 2): fluvoxamine (another medicine used in the treatment of depression), ciprofloxacin (an antibiotic) can modify the expected dose of agomelatine in your blood.
Thymanax« v poglavju 2): fluvoksamin (še enim zdravilom za zdravljenje depresije), ciprofloksacin (antibiotikom) lahko spremenita pričakovani odmerek agomelatina v krvi.
What Thymanax contains - The active substance is agomelatine.
Kaj vsebuje zdravilo Thymanax - Učinkovina je agomelatin.
What Thymanax looks like and contents of the pack Thymanax 25 mg film-coated tablets (tablet) are oblong, orange-yellow with a blue imprint of ‘company logo'
Izgled zdravila Thymanax in vsebina pakiranja Thymanax 25 mg filmsko obložene tablete (tablete) so podolgovate, oranžnorumene z modrim odtisom (logotip podjetja) na eni strani.
- Uncommon side effects (may affect up to 1 in 100 people): migraine, pins and needles in the fingers and toes (paraesthesia), blurred vision, restless legs syndrome (a disorder that is characterized by an uncontrollable urge to move the legs), ringing in the ears, excessive sweating (hyperhidrosis), eczema, pruritus, urticaria (hives), agitation, irritability, restlessness, aggressive behaviour, nightmares, mania/hypomania (see also under “Warnings and precautions” in section 2), suicidal thoughts or behaviour,confusion, weight decreased.
- Občasni neželeni učinki (lahko se pojavijo pri največ 1 od 100 bolnikov): migrena, mravljinčenje in zbadanje v prstih na rokah ter nogah (parestezije), zamegljen vid, sindrom nemirnih nog (motnja za katero je značilna nenadzorovana nuja po premikanju nog), zvonjenje v ušesih, prekomerno znojenje (hiperhidroza), ekcemi, srbenje, urtikarija (koprivnica), vznemirjenost, razdraženost, nemir, napadalno vedenje, nočne more, manija/hipomanija (glejte tudi »Opozorila in previdnostni ukrepi« v poglavju 2), razmišljanje o samomoru in samomorilno obnašanje, zmedenost, zmanjšanje telesne mase.
- If you are suffering from dementia, your doctor will make an individual evaluation of whether it is right for you to take Thymanax.
- Če imate demenco, bo vaš zdravnik individualno presodil, ali je za vas zdravljenje z zdravilom Thymanax primerno.
Caution should be exercised when Thymanax is administered to patients with pretreatment elevated transaminases (> the upper limit of the normal ranges and ≤3 times the upper limit of the normal range).
• Previdnost je potrebna pri predpisovanju bolnikom z zvišanimi vrednostmi aminotransferaz pred zdravljenjem (> zgornjo mejo normalnih vrednosti in ≤ 3-kratno zgornjo mejo normalnih vrednosti);
NAME OF THE MARKETING AUTHORISATION HOLDER Servier (Ireland) Industries Ltd
IME IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM Servier (Ireland) Industries Ltd
Consequently, co-administration of Thymanax with potent CYP1A2 inhibitors (e.g. fluvoxamine, ciprofloxacin) is contraindicated.
Sočasno jemanje agomelatina z močnimi zaviralci CYP1A2 (npr. fluvoksaminom in ciprofloksacinom) je zato kontraindicirano.
Thymanax contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free'.
Zdravilo Valdoxan vsebuje natrij To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na tableto, kar v bistvu pomeni ‘brez natrija'.
How to take THYMANAX
Kako jemati zdravilo Thymanax
Experience with agomelatine in overdose has indicated that epigastralgia, somnolence, fatigue, agitation, anxiety, tension, dizziness, cyanosis or malaise have been reported.
Pri izkušnjah s prevelikim odmerjanjem agomelatina so poročali o bolečini v epigastričnem predelu, somnolenci, utrujenosti, agitaciji, anksioznosti, napetosti, omotici, cianozi in občutku slabosti.
• printing ink : shellac, propylene glycol and indigo carmine aluminium lake (E132)
črnilo: šelak, propilenglikol in indigotin (E132).
Caution should be exercised when prescribing Thymanax with moderate CYP1A2 inhibitors (e.g. propranolol, enoxacin) which may result in increased exposure of agomelatine.
Pri sočasnem predpisovanju zdravila Thymanax z zmernimi zaviralci CYP1A2 (npr. propranololom, enoksacinom) morate biti previdni, saj se lahko zveča izpostavljenost agomelatinu.
Marketing Authorisation Holder Servier (Ireland) Industries Ltd Gorey road, Arklow, Co. Wicklow Ireland
IMETNIK DOVOLJENJA ZA PROMET Servier (Ireland) Industries Ltd Gorey Road, Arklow, Co. Wicklow Irska
These side effects include: - Very common side effects (may affect more than 1 in 10 people) :headache - Common side effects (may affect up to 1 in 10 people): dizziness, sleepiness (somnolence), difficulty in sleeping (insomnia), feeling sick (nausea), diarrhoea, constipation, abdominal pain, back pain, tiredness, anxiety, abnormal dreams, increased levels of liver enzymes in your blood, vomiting, weight increased.
- Pogosti neželeni učinki (lahko se pojavijo pri največ 1 od 10 bolnikov): omotica, zaspanost (somnolenca), težave s spanjem (nespečnost), siljenje na bruhanje (navzea), driska, zaprtje, bolečine v trebuhu, bolečine v hrbtu, utrujenost, tesnoba, nenormalne sanje, zvišana vrednost jetrnih encimov v krvi, bruhanje, povečanje telesne mase.
The experience of overdoses with Thymanax is limited but reported symptoms include pain in the upper part of the stomach, somnolence, fatigue, agitation, anxiety, tension, dizziness, cyanosis or malaise.
Izkušnje s prevelikim odmerjanjem zdravila Thymanax so omejene, poročali pa so o simptomih, kot so bolečine v zgornjem delu želodca, zaspanost, utrujenost, razdraženost, zaskrbljenost, napetost,
If you have trouble with your kidneys, your doctor will make an individual evaluation of whether it is safe for you to take Thymanax.
Če imate težave z ledvicami, bo zdravnik individualno presodil, ali je za vas zdravljenje z zdravilom
It is not advisable to drink alcohol while you are being treated with Thymanax.
Med zdravljenjem z zdravilom Thymanax ni priporočljivo piti alkohola.
Thymanax contains lactose.
Zdravilo Thymanax vsebuje laktozo.
You have been given Thymanax to treat your depression.
Zdravnik vam ga je predpisal za zdravljenje depresije.
Thymanax 25 mg film-coated tablets agomelatine
Thymanax 25 mg filmsko obložene tablete agomelatin
Thymanax contains lactose
Zdravilo Thymanax vsebuje laktozo
Warnings and precautions There could be some reasons why Thymanax may not be suitable for you:
V nekaterih primerih zdravilo Thymanax ni primerno za vas:
During treatment period Thymanax treatment should be discontinued immediately if: ‐ patient develops symptoms or signs of potential liver injury (such as dark urine, light coloured stools, yellow skin/eyes, pain in the upper right belly, sustained new-onset and unexplained fatigue).
Med zdravljenjem Zdravljenje z zdravilom Thymanax je treba takoj prekiniti: ‐ če se pri bolniku pojavijo simptomi ali znaki možne poškodbe jeter (kot je temen urin,
How to store Thymanax
Shranjevanje zdravila Thymanax
The calendar printed on the blister containing the tablets should help you remembering when you last took a tablet of Thymanax.
Da ne bi pozabili, kdaj ste nazadnje vzeli tableto zdravila Thymanax, si lahko pomagate s koledarčkom, natisnjenim na pretisnem omotu s tabletami.
NAME OF THE MEDICINAL PRODUCT Thymanax 25 mg tablets agomelatine
IME ZDRAVILA Thymanax 25 mg tablete agomelatin
The recommended dose of Thymanax is one tablet (25 mg) at bedtime.
Običajen odmerek je ena tableta (25 mg) zdravila Thymanax pred spanjem.
Breastfeeding should be discontinued if you take Thymanax.
Če jemljete zdravilo Thymanax, morate prenehati z dojenjem.
Thymanax 25 mg film-coated tablets are available in calendar blisters.
Thymanax 25 mg filmsko obložene tablete so na voljo v koledarskih pretisnih omotih po 14, 28, 56,
1 NAME OF THE MEDICINAL PRODUCT Thymanax 25 mg film-coated tablets
IME ZDRAVILA Thymanax 25 mg filmsko obložene tablete
You should discuss with your doctor on the best way of stopping your previous antidepressant medicine when starting Thymanax.
Ob začetku zdravljenja z zdravilom Thymanax se morate posvetovati z zdravnikom o najboljšem možnem načinu prenehanja jemanja prejšnjega antidepresiva.
Thymanax is for oral use.
Zdravilo Thymanax jemljite peroralno.
Servier Pharma SRL Tel: +4 021 528 52 80
Tel: +4 021 528 52 80
Latvija SIA Servier Latvia
România Servier Pharma SRL
(picture 6).
(slika 4).
E-mail: info@dompe.com
E-pošta: info@dompe.com
Week 4 Week 8 Week 4 Week 8
4. teden 8. teden 4. teden 8. teden
It may harm them,
Ko je nastavek za vialo pravilno nameščen,
• sensitivity to light;
• občutljivost na svetlobo,
However, no dose adjustment is considered necessary in these populations.
Kljub temu pri teh populacijah predvidoma ni potrebna prilagoditev odmerka.
The majority of side effects occur generally in and around the eyes.
Na splošno se večina neželenih učinkov pojavi v očeh in okoli njih.
Patients should be instructed to wash their hands before use.
Bolnikom je treba naročiti, da si pred uporabo zdravila umijejo roke.
The safety and efficacy of this medicinal product in children and adolescents below the age of 18 years have not been established.
Varnost in učinkovitost tega zdravila pri otrocih in mladostnikih, starih do 18 let, nista bili dokazani.
This medicine should not be used in children and adolescents below 18 years of age, as there is not enough information about its use in this age group.
Tega zdravila se pri otrocih in mladostnikih, starih do 18 let, ne sme uporabljati, saj ni dovolj podatkov o uporabi pri tej starostni skupini.
• abnormal sensation and discomfort in the eye, including feeling that there is something in the eye;
• nenormalen občutek in neugodje v očesu, vključno z občutkom, da imate nekaj v očesu,
The use of this medicine should be avoided during pregnancy.
Treba se je izogibati uporabi tega zdravila med nosečnostjo.
From a microbiological point of view, the method of opening (i.e. by connecting the vial adapter to the vial) precludes the risk of microbial contamination.
Z mikrobiološkega vidika način odpiranja (tj. z namestitvijo nastavka za vialo na vialo) preprečuje tveganje za mikrobiološko kontaminacijo.
Contact lenses could interfere with the correct use of this medicine.
Kontaktne leče bi lahko ovirale pravilno uporabo tega zdravila.
Fax +39 02 58383215
Faks: +39 02 58383215
For instructions on preparation and handling of the medicinal product before administration, see section 6.6.
Za navodila glede priprave in ravnanja s tem zdravilom pred dajanjem glejte poglavje 6.6.
pH 7.0-7.4 and osmolarity 280-320 mOsm/kg.
Vrednost pH 7,0-7,4 in osmolarnost 280-320 mOsm/kg.
Pull down the lower eyelid.
Povlecite spodnjo veko navzdol.
20122 Milano - Italy Tel. +39 02 583831
20122 Milano - Italija Tel.: +39 02 583831
Using more OXERVATE than is recommended is not likely to be harmful.
Uporaba večje količine zdravila OXERVATE od priporočene verjetno ni škodljiva.
It is recommended that these patients continue to be monitored for cancer progression during and after treatment with this medicinal product.
Priporoča se, da se te bolnike še naprej spremlja glede napredovanja raka očesa med zdravljenjem s tem zdravilom in po njem.
As soon as the patient is at home (and no later than 5 hours from when the patient receives the product at the pharmacy), the weekly carton should be placed into the refrigerator, at 2-8 °C.
Takoj ko je bolnik doma (in ne več kot 5 ur po tem, ko bolnik prejme zdravilo v lekarni), je treba tedensko škatlo spraviti v hladilnik pri temperaturi 2-8 °C.
• irritation in or around the eye;
• razdraženost v očesu ali okoli njega,
Via Campo di Pile, 67100 L'Aquila, Italy
Via Campo di Pile, 67100 L'Aquila, Italija
Pharmacotherapeutic Group: {not yet assigned}, ATC code: {not yet assigned}.
Farmakoterapevtska skupina: {še ni bila dodeljena}, oznaka ATC: {še ni bila dodeljena}.
• increase of tears (this could include symptoms such as discharge in the eye);
• povečanje količine solz (to lahko vključuje simptome, kot je izcedek iz oči),
The patient should be advised to contact the doctor in case of concern or a more severe eye reaction.
Bolniku je treba svetovati, da se v primeru zaskrbljenosti ali hujše očesne reakcije obrne na zdravnika.
The opened vial must be used within 12 hours of first opening.
Odprto vialo je treba uporabiti v 12 urah od prvega odprtja.
Results after 4 and 8 weeks of treatment
Rezultati po 4 in 8 tednih zdravljenja
Air bubbles may cause blockage and prevent the pipette from filling properly (especially at first withdrawal).
Zračni mehurčki lahko zamašijo pipeto in preprečijo, da bi se pravilno napolnila (še posebej pri prvem odvzemu raztopine).
They are ranked according to system organ class and classified according to the following convention: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), very rare (<1/10,000), or not known (cannot be estimated from the available data).
V okviru razvrstitve po organskih sistemih so neželeni učinki razvrščeni po naslednjih kategorijah pogostnosti: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1000 do < 1/100), redki (≥ 1/10.000 do < 1/1.000), zelo redki (< 1/10.000), neznana pogostnost (ni mogoče oceniti iz razpoložljivih podatkov).
Cenegermin may theoretically affect ocular cancer, as it is a growth factor.
Cenegermin teoretično lahko vpliva na rak očesa, saj je rastni dejavnik.
Use a new disinfectant wipe and a new pipette each time.
Vsakič uporabite nov razkužilni robček in novo pipeto.
Use of corticosteroids or eye drops containing preservatives
Uporaba kortikosteroidov ali kapljic za oko, ki vsebujejo konzervanse
If this happens, wait until your vision clears before you drive or use machines.
Če se to zgodi, počakajte, da se vam vid zbistri, preden upravljate vozila ali stroje.
A topical overdose is not likely to occur or to be associated with toxicity.
Ni verjetno, da bo prišlo do topikalnega prevelikega odmerjanja ali da bo povezano s toksičnostjo.
It should be noted that the frozen medicinal product received from the pharmacy could need up to 30 minutes for thawing.
Treba je upoštevati, da lahko odtajanje zamrznjenega zdravila, prejetega v lekarni, traja do 30 minut.
Make sure you do not touch your eye with the tip of the pipette.
Pazite, da se s konico pipete ne boste dotaknili očesa.
Cenegermin is a type of nerve growth factor (a human protein) which is naturally present on the eye surface.
Cenegermin je vrsta živčnega rastnega dejavnika (človeške beljakovine), ki je naravno prisoten na površini očesa.
Precautions to be taken before administering the medicinal product:
Previdnostni ukrepi, potrebni pred dajanjem zdravila:
* Recombinant form of human nerve growth factor produced in Escherichia Coli.
* Rekombinantna oblika humanega živčnega rastnega dejavnika, pridobljena v celicah Escherichia Coli.
Pharmacokinetic profiling of patients included in studies found no accumulation effect of cenegermin.
Farmakokinetično profiliranje bolnikov, vključenih v študiji, ni pokazalo učinka kopičenja cenegermina.
The multi-dose vial containing the product should be prepared according to the following instructions:
Večodmerno vialo zdravila je treba pripraviti po naslednjih navodilih:
The treatment has minor influence on the ability to drive and use machines, as it may cause temporary blurred vision or other visual disturbances, which is expected to last a few minutes after instillation.
To zdravljenje ima blag vpliv na sposobnost vožnje in upravljanja strojev, saj lahko začasno povzroči zamegljen vid ali druge motnje vida, za katere se pričakuje, da trajajo nekaj minut po vkapavanju.
If you use drops in both eyes, repeat the above instructions for your other eye using a new pipette (in this case, you will need to use 2 vials per day).
Če kapljice uporabljate v obeh očeh, zgornji postopek ponovite tudi za drugo oko, pri čemer uporabite novo pipeto (v tem primeru boste potrebovali 2 viali zdravila na dan).
If you wear contact lenses remove them before using this medicine and wait 15 minutes after using this medicine before reinserting them.
Če uporabljate kontaktne leče, jih pred uporabo tega zdravila odstranite in počakajte 15 minut po uporabi tega zdravila, preden jih ponovno vstavite.
Do not use a double dose to make up for the forgotten dose.
Ne vzemite dvojnega odmerka, če ste pozabili vzeti prejšnji odmerek.
Talk to your doctor before using this medicine: - if you have an infection in your eye, as the infection should be treated first.
Pred začetkom uporabe tega zdravila se posvetujte z zdravnikom: - če imate okužbo v očesu, saj jo je treba najprej ozdraviti.